These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19657064)

  • 1. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells.
    Han CT; Schoene NW; Lei KY
    Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1188-99. PubMed ID: 19657064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc-induced G2/M blockage is p53 and p21 dependent in normal human bronchial epithelial cells.
    Wong SH; Shih RS; Schoene NW; Lei KY
    Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1342-9. PubMed ID: 18353898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells.
    Fanzo JC; Reaves SK; Cui L; Zhu L; Lei KY
    Am J Physiol Cell Physiol; 2002 Aug; 283(2):C631-8. PubMed ID: 12107073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear accumulations of p53 and Mdm2 are accompanied by reductions in c-Abl and p300 in zinc-depleted human hepatoblastoma cells.
    Alshatwi AA; Han CT; Schoene NW; Lei KY
    Exp Biol Med (Maywood); 2006 May; 231(5):611-8. PubMed ID: 16636310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288).
    Meng LH; Kohn KW; Pommier Y
    Oncogene; 2007 Jul; 26(33):4806-16. PubMed ID: 17297446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN- and p53-mediated apoptosis and cell cycle arrest by FTY720 in gastric cancer cells and nude mice.
    Zheng T; Meng X; Wang J; Chen X; Yin D; Liang Y; Song X; Pan S; Jiang H; Liu L
    J Cell Biochem; 2010 Sep; 111(1):218-28. PubMed ID: 20506484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc deficiency depresses p21 gene expression: inhibition of cell cycle progression is independent of the decrease in p21 protein level in HepG2 cells.
    Wong SH; Zhao Y; Schoene NW; Han CT; Shih RS; Lei KY
    Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2175-84. PubMed ID: 17303651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isosilybin B causes androgen receptor degradation in human prostate carcinoma cells via PI3K-Akt-Mdm2-mediated pathway.
    Deep G; Oberlies NH; Kroll DJ; Agarwal R
    Oncogene; 2008 Jun; 27(28):3986-98. PubMed ID: 18332867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2, p53, p21 and pAKT protein pathways in benign neoplasms of the salivary gland.
    Marques YM; de Lima Mde D; de Melo Alves Sde M; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
    Oral Oncol; 2008 Sep; 44(9):903-8. PubMed ID: 18485798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3σ/Stratifin and p21 limit AKT-related malignant progression in skin carcinogenesis following MDM2-associated p53 loss.
    McMenemy CM; Guo D; Quinn JA; Greenhalgh DA
    Mol Carcinog; 2024 Sep; 63(9):1768-1782. PubMed ID: 38869281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDM2, P53, P21WAF1 and pAKT protein levels in genesis and behaviour of adenoid cystic carcinoma.
    de Lima Mde D; Marques YM; Alves Sde M; Freitas VM; Soares FA; de Araújo VC; Pinto Ddos S; Mantesso A
    Cancer Epidemiol; 2009 Aug; 33(2):142-6. PubMed ID: 19679062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H; Yu D; Agrawal S; Zhang R
    Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy.
    Mayo LD; Dixon JE; Durden DL; Tonks NK; Donner DB
    J Biol Chem; 2002 Feb; 277(7):5484-9. PubMed ID: 11729185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDM-2 antagonists induce p53-dependent cell cycle arrest but not cell death in renal cancer cell lines.
    Tsao CC; Corn PG
    Cancer Biol Ther; 2010 Dec; 10(12):1315-25. PubMed ID: 20953142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest.
    Giono LE; Manfredi JJ
    Mol Cell Biol; 2007 Jun; 27(11):4166-78. PubMed ID: 17371838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxyvitamin D(3) and PI3K/AKT inhibitors synergistically inhibit growth and induce senescence in prostate cancer cells.
    Axanova LS; Chen YQ; McCoy T; Sui G; Cramer SD
    Prostate; 2010 Nov; 70(15):1658-71. PubMed ID: 20583132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.